Cardiac Resynchronization Therapy Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Randomized investigation of the MitraClip device in heart failure: Design and rationale of the RESHAPE ‐HF2 trial design
ConclusionsThe RESHAPE-HF2 trial will provide sound evidence on the MitraClip device and its effects in HF patients with FMR. The recruitment was recently completed with 506 randomized patients. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - April 24, 2024 Category: Cardiology Authors: Stefan D. Anker, Tim Friede, Ralph Stephan von Bardeleben, Javed Butler, Kaneez Fatima, Monika Diek, Jutta Heinrich, Gerd Hasenfu ß, Wolfgang Schillinger, Piotr Ponikowski Tags: Study Design Source Type: research

Implication of geriatric nutritional risk index on treatment response and long-term prognosis in patients with cardiac resynchronization therapy
This study aims to explore the clinical implication of GNRI on treatment response and long-term clinical outcomes in heart failure (HF) patients receiving cardiac resynchronization therapy (CRT). (Source: International Journal of Cardiology)
Source: International Journal of Cardiology - April 24, 2024 Category: Cardiology Authors: Hao Huang, Bingqi Fu, Tianxin Long, Yu Yu, Sijing Cheng, Min Gu, Chi Cai, Xuhua Chen, Hongxia Niu, Wei Hua Source Type: research

The effect of sodium ‐glucose co‐transporter 2 inhibitors on outcomes after cardiac resynchronization therapy
ConclusionsWe observed an improvement in mortality in patients undergoing CRT prescribed SGLT2i compared with those not prescribed SGLT2i, despite similar degrees of reverse remodelling. The authors recommend starting SGLT2i prior to CRT implantation, where it does not delay implantation. (Source: ESC Heart Failure)
Source: ESC Heart Failure - April 23, 2024 Category: Cardiology Authors: Jonathan J.H. Bray, Marco Coronelli, Sam G.C. Scott, John A. Henry, Liam S. Couch, Mahmood Ahmad, Julian Ormerod, James Gamble, Timothy R. Betts, Andrew Lewis, Oliver J. Rider, Peregrine G. Green, Neil Herring Tags: Original Article Source Type: research

Initial experience with cardiac contractility modulation devices in Latin America for the treatment of heart failure
CONCLUSIONS: The modulation of cardiac contractility is currently a treatment option for patients with heart failure in functional class III-IV, with LVEF 25-45%, and a QRS < 130 ms who are not candidates for cardiac resynchronization therapy.PMID:38631374 | DOI:10.24875/ACM.24000021 (Source: Archivos de Cardiologia de Mexico)
Source: Archivos de Cardiologia de Mexico - April 17, 2024 Category: Cardiology Authors: Ulises Rojel-Mart ínez Carlos De-la-Fuente-Macip Arturo Enr íquez-Silverio Karla I Bozada-Nolasco Pablo A Re átiga-Vega Flor M Marquez Marquez-Maldonado Source Type: research

Effect of adaptive cardiac resynchronization therapy in heart failure patients with pacemaker dependency
ConclusionThe aCRT algorithm significantly reduced the risk of adverse clinical outcomes in patients with pacemaker dependency. This algorithm may be an important tool for managing such patients. (Source: Journal of Interventional Cardiac Electrophysiology)
Source: Journal of Interventional Cardiac Electrophysiology - April 17, 2024 Category: Cardiology Source Type: research

Correction to: Effects of Synchronizing Foot Strike and Cardiac Phase on Exercise Hemodynamics in Patients With Cardiac Resynchronization Therapy: A Within-Subjects Pilot Study to Fine-Tune Cardio-Locomotor Coupling for Heart Failure
Circulation. 2024 Apr 16;149(16):e1130. doi: 10.1161/CIR.0000000000001249. Epub 2024 Apr 15.NO ABSTRACTPMID:38620088 | DOI:10.1161/CIR.0000000000001249 (Source: Circulation)
Source: Circulation - April 15, 2024 Category: Cardiology Source Type: research

Impact of atrial fibrillation on 1-year outcome in patients with implantable cardioverter defibrillator or cardiac resynchronization therapy with defibrillator: results from the German DEVICE Registry
CONCLUSIONS: Our clinical data on an extended cohort of contemporary patients confirm the significant impact of AF, and its associated comorbidities, upon mortality and major adverse events after implantation of ICD/CRT.PMID:38617758 | PMC:PMC11009579 | DOI:10.21037/jtd-23-274 (Source: Journal of Thoracic Disease)
Source: Journal of Thoracic Disease - April 15, 2024 Category: Respiratory Medicine Authors: Sebastian Feickert Niels Christian Ewertsen Julia K öbe Thomas Kleemann Joachim Jehle Jochen Senges Matthias Hochadel Dietrich Andresen Christoph Stellbrink Lars Eckardt Stefan Spitzer Johannes Brachmann H üseyin Ince Giuseppe D'Ancona Source Type: research

Impact of High-Voltage Device Implantation in Elderly Japanese Patients With Heart Failure as Primary Prevention 　- Post Hoc Analysis of HINODE
CONCLUSIONS: Although elderly patients may have a higher risk of mortality in general, the benefit of HVD therapy in this group is comparable to that in non-elderly patients.PMID:38616125 | DOI:10.1253/circj.CJ-23-0801 (Source: Circulation Journal)
Source: Circulation Journal - April 14, 2024 Category: Cardiology Authors: Yoshinari Enomoto Takanori Ikeda Keijiro Nakamura Mahito Noro Kaoru Sugi Masao Moroi Masato Nakamura Kengo Kusano Torri Schwartz Torsten Kayser Kazutaka Aonuma Source Type: research

Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: Long ‐term outcomes
ConclusionThe BeAT-HF primary endpoint was neutral; however, BAT provided safe, effective, and sustainable improvements in HFrEF patient's functional status, 6MHWD and QOL. (Source: European Journal of Heart Failure)
Source: European Journal of Heart Failure - April 12, 2024 Category: Cardiology Authors: Michael R. Zile, JoAnn Lindenfeld, Fred A. Weaver, Faiez Zannad, Elizabeth Galle, Tyson Rogers, William T. Abraham Tags: Research Article Source Type: research